Ozmosi | VX-993 Drug Profile Vertex is developing VX-993 as a treatment for pain. (Sourced from: https://clinicaltrials.gov/study/NCT05653323)

Second drug in pipeline stage 2 trials for #Neuropathy

VX-993 #VX993

pryzm.ozmosi.com/product/28048

#Cure4Pain currently enrolling patients with Diabetic and other Neuropathies